# Step 231 — Prescription integration acceptance

2026-10-28 (America/Toronto). **Save/reopen/display PASS. Conflicting-value overwrite protection BLOCKED because the selected existing Draft's name/address were blank. Direct audit-row inspection was unavailable.** One existing unsigned Draft was saved once; no new directory, patient or prescription was created. **DE09.032 and PC07.01 remain PARTIAL; mandatory inventory remains 7 IDs / 3 packages.**

## 1. Branch/worktree preservation

Actual branch was **main**, with a clean tracked/untracked worktree at entry. This differs from the earlier feature-branch report; no branch assumption or switch was made. Preserved the existing source, tests and certification evidence: all twelve relevant pre-existing file hashes matched before/after. Created only this report. `git diff --check` passed.

No implementation/configuration/SQL/migration/test change, staging, commit, push, pull, fetch, merge, reset, clean or stash occurred. No build, suite, restart, backup/restore or database preparation was performed. API **16624**, Web **17244** and Auth **10124** retained their existing start times; API continued using the Step 229 artifact activated in Step 230.

## 2. Authentication, tenant and fixture identity clarification

The owner manually signed in in a separate normal browser window. Codex performed application navigation/testing. The authenticated page selected **local-dev-fresh**, tenant UID **f94c6ecd-4417-483e-8a94-0507cf8384c2**. No passwords were retrieved from source/configuration; no authentication cookies/tokens were extracted or logged.

The Step 231 prompt listed `urn:microemr:dev-test:dispensing-location`, but Step 230 recorded the actual fixture under `urn:microemr:dev-test`. Before any save, the owner explicitly selected **“Reuse the actual Step 230 fixture under urn:microemr:dev-test.”** No identity was silently substituted or changed.

Reused the single existing active entry and verified its maintenance details:

| Field | Actual reused fixture |
|---|---|
| Directory UID | **a4534d8b-479c-44c9-bf34-f81159c71ff8** |
| Name | MicroEMR DEV TEST Dispensing Location |
| System | `urn:microemr:dev-test` |
| Identifier | `step228-location-001` |
| Address | 100 Test Street, Toronto, ON |

The identifier search supplied exactly one entry. No Add/Edit/Deactivate/Reactivate directory submission occurred. This remains a synthetic test location with no external-verification claim.

## 3. Existing Draft eligibility

Used one existing disposable development prescription found through the normal patient-chart UI. Technical audit pointer: prescription UID **8eb1c3a6-f652-4d31-a212-14aa45a8e193**. Patient identity and clinical contents are omitted.

The chart showed **Draft**, no View/Print artifact link, and the normal **Edit Prescription Draft** GET returned HTTP 200. The normal private-note editor reported `canEdit: true`, supporting original-prescriber edit eligibility through existing application controls. The selected tenant was confirmed again. No new prescription/patient was manufactured. No sign, finalize, transmit, dispense, correction or cancellation operation was invoked; eligibility evidence concerns the application's native unsigned Draft state, not an external delivery-service investigation.

Both existing dispensing name/address values were **blank**, with no conflict against the directory. This prerequisite limitation was identified before saving; no conflicting values or additional records were manufactured to force the warning.

## 4. Save, reopen and display — PASS

Through the normal Draft editor:

1. Searched for `step228-location-001`; normal lookup returned **HTTP 200**, exactly one result.
2. Selected it; normal lookup Detail returned **HTTP 200**, and the preview matched system/identifier/name/address.
3. Observed the population checkbox initially **unchecked**. Explicitly checked the confirmation to copy the fixture's name/address, then clicked **Use this location**. Verified all selected fields and the directory UID in the form.
4. Clicked **Save Changes exactly once**, using normal form validation and antiforgery handling. `POST /PatientPrescriptions/Edit` returned **HTTP 200**, `success: true`, and navigated back to the chart. Its target prescription UID matched the selected Draft.
5. Reopened that same Draft through its normal Edit button: **HTTP 200**. System/identifier/name/address all matched the selected fixture; RowVersion changed. The record remained **Draft**, without an artifact. All **28 other clinical field groups compared** between the before/after editor models were unchanged; these comparisons do not constitute a database-wide snapshot.
6. Opened its normal full Detail view: **HTTP 200**. The exact system and identifier displayed, the confirmed facility name/address displayed, and the provenance text stated that the tenant-local directory selection was checked when saved. Status still displayed **Draft**.

Save interaction window: **2026-10-28T20:37:09.257Z–20:37:12.436Z**, **16:37:09–16:37:12 EDT**. Reopen/display used fresh normal application reads, not the unsaved selection preview. No second save was submitted. The browser was closed after verification.

## 5. Overwrite protection — BLOCKED

The chosen Draft did not contain conflicting existing name/address values. The mismatch warning was accordingly not visible. The replacement checkbox was initially unchecked; the tool explicitly checked it before copying details, and the final saved values matched that confirmation.

This demonstrates explicit population from blank values, **not** protection of pre-existing conflicting values. Per the Step 231 instruction, record that missing-conflict scenario as **BLOCKED**, not PASS. No temporary conflicting field values or additional patient/prescription records were introduced.

**Two requested acceptance checks: PASS 1 / FAIL 0 / BLOCKED 1 / NOT TESTED 0.** No functional failure was observed.

## 6. Audit observation and preservation qualifications

Attempted focused read-only SQL access to the known development endpoint/database using the current **Windows identity only**, without reading any stored connection credentials. Connection opening timed out (`SqlErrorNumber -2`); no SELECT ran and no audit/preservation snapshot was obtained. Did not retry with passwords or retrieve secrets. The exposed platform security-audit controller is not evidence of the tenant's clinical `AuditLog` row.

**Direct observation of the expected `PrescriptionDraftUpdated` audit row: NOT VERIFIED / BLOCKED by unavailable read-only access.** The expected review target is `dbo.AuditLog`, `EntityName = PatientPrescription`, `EntityId = 8eb1c3a6-f652-4d31-a212-14aa45a8e193`, `ActionName = PrescriptionDraftUpdated`, around **20:37 UTC**. Review should confirm the trusted actor and the saved system/identifier/directory UID in its existing snapshot. Earlier transactional audit/rollback evidence is reused, but a successful application save is not presented as an independently inspected live audit row.

Action-scope evidence confirms one prescription Edit POST targeting this Draft; no directory creation, other prescription mutation, finalized-artifact action or unrelated-patient mutation was requested by the acceptance commands. Normal chart navigation also issued **three automatic CDS-evaluation POSTs for the same selected patient**. These were application-driven requests, not extra prescription saves; their database effects were not independently inspected.

The saved prescription remained Draft and 28 other compared field groups were unchanged. **A database-wide assertion that no concurrent/unrelated record or finalized artifact changed is not claimed**, because read-only before/after database inspection was unavailable. No broad security/isolation suite or historical artifact test was repeated to substitute for that missing live observation.

## 7. Reused evidence and remaining mandatory requirements

Reused Steps **218, 225, 229 and 230**: Stage 2 automated evidence, applied migrations 0098/0099, three verified directory EXECUTE grants, 18 focused RowVersion cases/build PASS, and four live directory checks PASS. No new migration, grant, fixture, restart, test suite or backup/recovery assessment was performed.

Keep **DE09.032 PARTIAL**: persistence now has live evidence, but conflicting-value protection and direct live update-audit inspection remain qualified. Do not recommend closure yet. Keep **PC07.01 PARTIAL** and the retained mandatory inventory **7 IDs / 3 packages**:

- Prescribing: **PC04.01, PC04.06, PC04.07, PC04.09, PC04.14**.
- CPP: **PC07.01**.
- Scheduling: **PC09.03**.

This is the retained inventory, not a repeated certification assessment. Existing DE09.034/DE09.035 qualifications and other accepted evidence remain unchanged. No closure/inventory file was edited.

## 8. Recommended Step 232

Resolve only the two evidence limitations: establish an owner-approved, credential-safe read-only route to inspect the exact Draft update audit row, and perform one warning/confirmation check with genuinely conflicting existing name/address values under an explicitly bounded acceptance scope. Reuse current data; if a suitable conflict is unavailable, report that prerequisite or obtain separate authorization for any necessary fixture adjustment before making it. Do not create another directory location, patient or prescription, and do not repeat completed persistence or broad regression checks without a new reason.
